We are monitoring the impact of COVID-19 on Latin America Plasma Fractionation Market Get in touch with us for detailed analysis Know More
Share on

Latin America Plasma Fractionation Market Research Report – Segmented By Product, Application, End User & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVId-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2723
Pages: 145

Latin America Plasma Fractionation Market Size (2022 to 2027)

The size of the Latin American Plasma Fractionation Market size was worth USD 3.51 billion in 2022. This value is projected to be growing at a CAGR of 5.2% to touch USD 4.53 billion by 2027.

Plasma is the liquid portion of blood. It consists of red cells, white cells, and platelets suspended in it and also contains thousands of distinct proteins and other materials like electrolytes, minerals, hormones, etc., which are essential for the regular function of the human body. Plasma supports in maintaining blood pressure and body temperature management.

There are many therapeutic uses for the proteins present in plasma. For example, Albumin is commonly used to rejuvenate and maintain blood volume after traumatic injury, surgery, and plasma interchange.

The increasing demand for plasma proteins and the increasing prevalence of rare diseases across Latin America is expected to propel the Latin America plasma fractionation market. In addition, the growth of the Latin America Plasma Fractionation Market is further driven by factors such as the high prevalence of blood disorders spread among a vast population base, growing awareness about blood abnormalities, and the leaps in technological, clinical advancements.

Adversarial reactions associated with the procedure of plasma fractionation and transfer, high costs of plasma products, and unfavorable reimbursement policies are the main constraints of market growth. In addition, high prices of plasma derivatives and the risk factors, coupled with the rising utilization of recombinant proteins and products that behave as a substitute for the plasma products, are expected to hamper the growth of the Latin American plasma fractionation market.

This research report on the Latin America plasma fractionation market has been segmented and sub-segmented into the following categories:

By Product: 

  • Albumin
  • Immunoglobulin
  • Factor VIII
  • Protease Inhibitors

By Application: 

  • Neurology
  • Hematology
  • Rheumatology
  • Pulmonology
  • Immunology

By End User: 

  • Hospitals
  • Clinical Laboratories

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

In Latin America, the Brazilian plasma fractionation market dominated Latin American in 2020 due to the rise in plasma collection and the number of plasma collection centers. Besides, the increasing incidences of blood and immune disorders are owing to the rising geriatric population.

The Mexican plasma fractionation market is projected to showcase a significant growth rate during the forecast period. Increasing demand from patients for excellent and technically advanced healthcare facilities and increased acquisition of innovative and advanced technologies boost Mexico's market. Rising off-label utilization of critical plasma products such as albumins is expected to drive the Mexico plasma fractionation market.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the Latin American plasma fractionation market profiled in the report are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Français du Fractionnement et des Biotechnologies (France).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Fractionation Process         

                                5.1.3 Immunoglobulin   

                                5.1.4 Coagulation Factor Concentrates  

                                5.1.5 Albumin   

                                5.1.6 Protease Inhibitors              

                                5.1.7  Y-o-Y Growth Analysis, By Product              

                                5.1.8  Market Attractiveness Analysis, By Product            

                                5.1.9  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Neurology               

                                5.2.3 Immunology           

                                5.2.4 Hematology            

                                5.2.5 Critical Care             

                                5.2.6 Pulmonology          

                                5.2.7 Hemato-Oncology               

                                5.2.8 Rheumatology       

                                5.2.9 Other Application 

                                5.2.10 Y-o-Y Growth Analysis, By Application      

                                5.2.11 Market Attractiveness Analysis, By Application    

                                5.2.12 Market Share Analysis, By Application      

                5.3 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Clinical Laboratories            

                                5.4.4 Academic Institutes            

                                5.4.5 Y-o-Y Growth Analysis, By End User             

                                5.4.6  Market Attractiveness Analysis, By End User          

                                5.4.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxalta Incorporated                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 CSL Ltd.                        

                8.3 Grifols S.A                   

                8.4 Octapharma AG                        

                8.5 Kedrion S.p.A                            

                8.6 Bio Products Laboratory                        

                8.7 Sanquin                        

                8.8 China Biologic Products, Inc.                

                8.9 Biotest AG                  

                8.10 Laboratoire Français du Fractionnement et des Biotechnologies                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  2. Latin America Immunoglobulin Market, By Region, From 2022 - 2027 (USD Million)
  3. Latin America Coagulation Factor Concentrates Market, By Region, From 2022 - 2027 (USD Million)
  4. Latin America Albumin Market, By Region, From 2022 - 2027 (USD Million)
  5. Latin America Protease Inhibitors Market, By Region, From 2022 - 2027 (USD Million)
  6. Latin America Other Plasma Products Market, By Region, From 2022 - 2027 (USD Million)
  7. Latin America Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  8. Latin America Neurology Market, By Region, From 2022 - 2027 (USD Million)
  9. Latin America Immunology Market, By Region, From 2022 - 2027 (USD Million)
  10. Latin America Hematology Market, By Region, From 2022 - 2027 (USD Million)
  11. Latin America Critical Care Market, By Region, From 2022 - 2027 (USD Million)
  12. Latin America Pulmonology Market, By Region, From 2022 - 2027 (USD Million)
  13. Latin America Hemato-oncology Market, By Region, From 2022 - 2027 (USD Million)
  14. Latin America Rheumatology Market, By Region, From 2022 - 2027 (USD Million)
  15. Latin America Other Applications Market, By Region, From 2022 - 2027 (USD Million)
  16. Latin America Plasma Fractionation Market, By End User, From 2022 - 2027 (USD Million)
  17. Latin America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  18. Latin America Clinical Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  19. Latin America Academic Institutes Market, By Region, From 2022 - 2027 (USD Million)
  20. Brazil Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  21. Brazil Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  22. Brazil Plasma Fractionation Market, By End User, From 2022 - 2027 (USD Million)
  23. Argentina Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  24. Argentina Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  25. Argentina Plasma Fractionation Market, By End User, From 2022 - 2027 (USD Million)
  26. Mexico Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  27. Mexico Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  28. Mexico Plasma Fractionation Market, By End User, From 2022 - 2027 (USD Million)
  29. Rest of Latin America Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  30. Rest of Latin America Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  31. Rest of Latin America Plasma Fractionation Market, By End User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample